Enhancement Drugs and Women

When took place: 25 Feb 2021, 7.30pm (AUS time)

Program:

  • 7.30-7.40pm: Welcome
  • 7.40pm-7.50pm: Ingrid Amalia Havnes
  • 7.50-8.00pm: Séverine Lamon
  • 8.00-8.10pm: Alexandra Aldridge
  • 8.10-8.20: Kathryn Henne
  • 8.30-8.40pm: Chris, personal trainer
  • 8.30-8.55: Discussion
  • 8.55-9.00pm: Future steps

Moderator: Matthew Dunn

Speakers:

  • Ingrid Amalia Havnes, MD, PhD, Researcher and specialist in psychiatry, National Advisory Unit on Substance Use Disorder treatment, Division of Mental Health and Addiction, Oslo University Hospital, Norway

Havnes is engaged in research projects focusing on anabolic steroid use in subpopulations (women, prisoners, patients in addiction treatment), desired and undesired effects of anabolic steroid use and treatment of related health problems. She has conducted research exploring experiences among female users of steroids and other enhancement drugs with focus on masculinizing and sexual effects, bodily change, and psychoactive substance use.

  • Séverine Lamon, PhD, School of Exercise and Nutrition Sciences, Deakin University

Séverine Lamon is an Associate Professor within Deakin University’s School of Exercise and Nutrition Sciences in Melbourne, Australia. Séverine is a muscle physiologist with an anti-doping background, and she developed an original anti-doping test as part of her PhD within the Swiss Anti-Doping Laboratory. For the last decade, her main research focus has been the regulation of skeletal muscle mass in health and disease. She has established a practical framework to investigate the regulation of skeletal muscle mass in females, and has a particular interest in understanding the molecular role of testosterone in female skeletal muscle adaptation.

  • Alexandra Aldridge, PhD Candidate at Royal Holloway, University of London

Alexandra Aldridge is a third year PhD student in the Department of Law and Criminology at Royal Holloway, University of London. Her doctoral research explores people’s experiences of sex on drugs and related issues around sexual ethics. She is particularly interested in women’s experiences of sex on drugs given the tendency of existing sex-on-drug research to restrict its focus to men who have sex with men engaging in ‘chemsex’.

  • Kathryn (Kate) Henne, Professor and Director, School of Regulation and Global Governance, The Australian National University

Kathryn (Kate) Henne’s research engages critical issues in biopolitics, gender and governance. She has published widely on the regulation of human enhancement, including both gendered and queer perspectives. Most of her work on enhancement drugs has focused on sport and physical culture, illustrating how the tendency to focus on men’s experiences can overlook important distinctions and nuances that emerge when studying diverse groups of women.

  • Chris, a personal trainer who has experience with training women who use anabolic-androgenic steroids and other enhancement drugs.

The personal trainer will discuss issues she has encountered in the bodybuilding and fitness industry when it comes to women who use anabolic-androgenic steroids and other enhancement drugs. She will also talk about what needs to be done to support these women and what actions should be undertaken to resolve these issues.